Testing for IgA anti-tissue transglutaminase in routine clinical practice: Requesting behaviour in relation to

Maurits Damoiseaux1, William van Doorn1, Ellen van Lochem2

  • 1Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, the Netherlands.

Insights

Laboratory testing for coeliac disease shows a low positive rate (<2%) for IgA anti-TTG. Guidelines may need refinement to improve the pre-test probability for accurate diagnosis.

Area of Science:

  • Clinical immunology
  • Gastroenterology
  • Laboratory medicine

Background:

  • Increased awareness and improved serological tests for coeliac disease have led to a rise in laboratory test requests.
  • Understanding requesting patterns across clinical disciplines is crucial for optimizing diagnostic strategies.

Purpose of the Study:

  • To evaluate the requesting behavior of different clinical disciplines for coeliac disease serology.
  • To analyze the prevalence of positive results in relation to existing guidelines.
  • To assess the adherence to diagnostic confirmation protocols.

Main Methods:

  • Retrospective analysis of laboratory data over 5 years from tertiary and secondary hospitals.
  • Comparison of requesting patterns and positive result rates across clinical disciplines.

Main Results:

  • Initial IgA anti-TTG testing yielded a low positive rate (<2%), with slightly higher rates in paediatric patients (2.4-4.0%).
  • Confirmation of positive results via IgA anti-endomysium antibodies in an independent sample was infrequent, particularly in paediatric cases.
  • Follow-up measurements were common for monitoring gluten-free diet compliance rather than initial diagnosis.

Conclusions:

  • The low overall positive rate for IgA anti-TTG suggests a need to refine clinical indications for coeliac disease testing to enhance pre-test probability.
  • Emphasis on confirming positive serology in an independent sample is critical, especially for paediatric coeliac disease diagnosis, to potentially avoid biopsy.
Abstract